Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer

BACKGROUND: Radiation with platinum-based chemotherapy is the standard of care for unresectable stage III non-small cell lung cancer (NSCLC). Despite aggressive treatment, progression-free survival and overall survival remain poor. It is unclear whether any tumor genetic mutations are associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Leo Y., Samstein, Robert M., Dick-Godfrey, Rosalind, Sidiqi, Baho, Wang, Chunyu, Oro, Federica, Sonnick, Mark, Paik, Paul K., Chaft, Jamie E., Shaverdian, Narek, Gomez, Daniel R., Rimner, Andreas, Wu, Abraham J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897765/
https://www.ncbi.nlm.nih.gov/pubmed/33665490
http://dx.doi.org/10.1016/j.adro.2020.10.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897765/
https://www.ncbi.nlm.nih.gov/pubmed/33665490
http://dx.doi.org/10.1016/j.adro.2020.10.027

Ejemplares similares